XML 43 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Cash Flows [Abstract]    
Interest Paid, Excluding Capitalized Interest, Operating Activities $ 4,214 $ 4,227
OPERATING ACTIVITIES    
Net income 3,064 3,496
Undistributed Earnings Of Equity Method And Other Investments (94) (57)
Reconciliation of net income to net cash provided by operating activities:    
Provision for loan losses 788 34
Depreciation 668 731
Amortization of OMSR 97 44
Amortization of acquisition intangibles 13 19
Net amortization of AFS securities 444 435
Debt Securities, Available-for-sale, Realized Gain (Loss) (71) 0
Net gain on sale of mortgage loans (151) (93)
Mortgage Servicing Rights (MSR) Impairment (Recovery) 245 0
Bank Owned Life Insurance Income, Net of Expense 170 173
Other Real Estate, Foreclosed Assets, and Repossessed Assets, Valuation Adjustments 42 33
Bank Owned Life Insurance Income, From Policy Redemption (524) 0
Share-based payment awards under equity compensation plan 123 131
Proceeds from loan sales (8,890) (6,520)
Proceeds from loan sales 8,717 6,826
Net changes in operating assets and liabilities which provided (used) cash:    
Accrued interest receivable (521) (823)
Other assets (379) (1,492)
Accrued interest payable and other liabilities (111) 437
Net cash provided by (used in) operating activities 3,394 3,076
Activity in AFS securities    
Proceeds from Sale of Debt Securities, Available-for-sale 26,855 0
Maturities and calls 12,674 11,824
Purchases (11,012) (6,313)
Net loan principal (originations) collections 10,487 (16,373)
Proceeds from sales of foreclosed assets 51 224
Purchases of premises and equipment (372) (340)
Proceeds from Life Insurance Policy 1,458 0
Payments to Acquire Other Investments 150 117
Net cash provided by (used in) investing activities 39,991 (11,095)
FINANCING ACTIVITIES    
Net increase (decrease) in deposits 8,232 (14,730)
Increase in other borrowed funds (12,828) (28,615)
Cash dividends paid on common stock (2,122) (2,043)
Proceeds from issuance of common stock 1,330 1,433
Common stock repurchased (1,168) (632)
Common stock purchased for deferred compensation obligations (650) (186)
Increase (decrease) in cash and cash equivalents 36,179 (52,792)
Cash and cash equivalents at beginning of period 60,572 73,471
Cash and cash equivalents at end of period 96,751 20,679
Net cash provided by (used in) financing activities (7,206) (44,773)
SUPPLEMENTAL NONCASH INFORMATION:    
Transfers of loans to foreclosed assets $ 117 $ 237